News

Data show NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors

NeoCast occluded approximately five times more vessel branches compared to the market-leading liquid embolic agent in swine kidneys

Interview with Upma Sharma, President and CEO of Arsenal Medical